+404.9%
CORZ vs MRNA
+32.4%
+372.6%
-64.9%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 10y.
| Period | Portfolio | MRNA | Excess | Alpha |
|---|---|---|---|---|
| 1D | -4.0% | +0.7% | -4.7% | -4.0% |
| 7D | -3.0% | -8.2% | +5.3% | -2.6% |
| 30D | -12.1% | +125.6% | -137.7% | -18.8% |
| 3M | -32.4% | +197.1% | -229.5% | -41.4% |
| 6M | +12.4% | +148.5% | -136.1% | +0.1% |
| YTD | +19.3% | +363.3% | -344.0% | -5.3% |
| 1Y | +8.6% | +462.0% | -453.4% | -17.2% |
| All | +404.9% | +32.4% | +372.6% | +347.3% |
Cumulative growth
Daily Returns
Daily percentage return beside MRNA.
Daily Out/Under-Performance
Portfolio return minus MRNA return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × MRNA return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 10y: compounded portfolio wealth divided by compounded MRNA wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
10y analysis · Full analysis span regression · 6 months rolling